Annual Shareholders Equity
-$8.83 M
-$12.11 M-369.25%
December 1, 2023
Summary
- As of February 7, 2025, NLSP annual stockholders equity is -$8.83 million, with the most recent change of -$12.11 million (-369.25%) on December 1, 2023.
- During the last 3 years, NLSP annual shareholders equity has risen by +$150.50 thousand (+1.68%).
- NLSP annual shareholders equity is now -369.25% below its all-time high of $3.28 million, reached on December 31, 2022.
Performance
NLSP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$9.27 M
-$434.70 K-4.92%
June 1, 2024
Summary
- As of February 7, 2025, NLSP quarterly stockholders equity is -$9.27 million, with the most recent change of -$434.70 thousand (-4.92%) on June 1, 2024.
- Over the past year, NLSP quarterly shareholders equity has dropped by -$4.98 million (-116.21%).
- NLSP quarterly shareholders equity is now -318.13% below its all-time high of $4.25 million, reached on June 30, 2021.
Performance
NLSP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NLSP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -369.3% | -116.2% |
| 3 y3 years | +1.7% | -116.2% |
| 5 y5 years | -0.2% | -116.2% |
NLSP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -369.3% | at low | -382.5% | at low |
| 5 y | 5-year | -369.3% | +1.7% | -318.1% | at low |
| alltime | all time | -369.3% | +1.7% | -318.1% | at low |
NLS Pharmaceutics AG Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -$9.27 M(+4.9%) |
| Dec 2023 | -$8.83 M(-369.3%) | -$8.83 M(+106.1%) |
| Jun 2023 | - | -$4.29 M(-230.7%) |
| Dec 2022 | $3.28 M(+504.9%) | $3.28 M(-181.2%) |
| Jun 2022 | - | -$4.04 M(-845.1%) |
| Dec 2021 | $542.40 K | $542.40 K(-87.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $4.25 M(-147.3%) |
| Dec 2020 | -$8.98 M(+45.6%) | -$8.98 M(+22.5%) |
| Jun 2020 | - | -$7.33 M(+18.8%) |
| Dec 2019 | -$6.17 M(-30.0%) | -$6.17 M(+47.0%) |
| Jun 2019 | - | -$4.20 M(-52.4%) |
| Dec 2018 | -$8.81 M(+14.2%) | -$8.81 M |
| Dec 2017 | -$7.72 M | - |
FAQ
- What is NLS Pharmaceutics AG annual stockholders equity?
- What is the all time high annual shareholders equity for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual shareholders equity year-on-year change?
- What is NLS Pharmaceutics AG quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG quarterly shareholders equity year-on-year change?
What is NLS Pharmaceutics AG annual stockholders equity?
The current annual shareholders equity of NLSP is -$8.83 M
What is the all time high annual shareholders equity for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual stockholders equity is $3.28 M
What is NLS Pharmaceutics AG annual shareholders equity year-on-year change?
Over the past year, NLSP annual stockholders equity has changed by -$12.11 M (-369.25%)
What is NLS Pharmaceutics AG quarterly stockholders equity?
The current quarterly shareholders equity of NLSP is -$9.27 M
What is the all time high quarterly shareholders equity for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high quarterly stockholders equity is $4.25 M
What is NLS Pharmaceutics AG quarterly shareholders equity year-on-year change?
Over the past year, NLSP quarterly stockholders equity has changed by -$4.98 M (-116.21%)